Skip to main content
Premium Trial:

Request an Annual Quote

Catherine Sazdanoff, John McIlwraith

Catherine Sazdanoff and John McIlwraith have been elected independent directors to Meridian Biosciences' board, effective Aug. 14. 

Sazdanoff is the CEO and president of Sazdanoff Consulting. Between 2006 and 2015, she held various executive positions at Takeda Pharmaceutical International, including vice president, head of corporate projects; VP global business development; and VP corporate development. Prior to Takeda, Sazdanoff spent 22 years at Abbott Laboratories. 

McIlwraith co-founded venture capital firm Allos Ventures in 2010 and has been a managing director there since then. Prior to that, he was a managing director at Blue Chip Venture. He currently is the lead director at Assurex Health. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more